Water → HCID 24852342, compound
Reaction equation
[H-].[H-].[H-].[H-].[Li+].[Al+3].[F:7][C:8]1[CH:13]=[CH:12][C:11]([C:14]2[N:15]=[C:16](/[CH:24]=[CH:25]/[C:26]3[CH:31]=[CH:30][C:29]([N:32]4[CH:36]=[C:35]([CH3:37])[N:34]=[CH:33]4)=[C:28]([O:38][CH3:39])[CH:27]=3)[N:17]3[CH2:22][CH2:21][O:20][C:19](=[O:23])[C:18]=23)=[CH:10][CH:9]=1.O.[OH-].[Na+].[CH2:43]1COCC1>CO>[F:7][C:8]1[CH:9]=[CH:10][C:11]([C:14]2[N:15]=[C:16](/[CH:24]=[CH:25]/[C:26]3[CH:31]=[CH:30][C:29]([N:32]4[CH:36]=[C:35]([CH3:37])[N:34]=[CH:33]4)=[C:28]([O:38][CH3:39])[CH:27]=3)[N:17]3[CH2:22][CH2:21][O:20][CH2:19][C:18]=23)=[CH:12][CH:13]=1.[F:7][C:8]1[CH:9]=[CH:10][C:11]([C:14]2[N:15]=[C:16](/[CH:24]=[CH:25]/[C:26]3[CH:31]=[CH:30][C:29]([N:32]4[CH:36]=[C:35]([CH3:37])[N:34]=[CH:33]4)=[C:28]([O:38][CH3:39])[CH:27]=3)[N:17]([CH2:22][CH2:21][OH:20])[C:18]=2[CH2:19][O:23][CH3:43])=[CH:12][CH:13]=1Participants
Procedure
LAH (1 mg) was added to a solution of 1-(4-fluorophenyl)-3-{(E)-2-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]vinyl}-5,6-dihydroimidazo[5,1-c][1,4]oxazin-8-one (5 mg) in THF (1 mL), and the reaction solution was stirred at room temperature for 30 minutes. Water (0.01 mL), a 5 N sodium hydroxide solution (0.01 mL), water (0.03 mL) and methanol (5 mL) were sequentially added to the reaction solution. The suspension was filtered through celite, and the filtrate was concentrated under reduced pressure. p-Toluenesulfonic acid monohydrate (6 mg) was added to a solution of the resulting residue in toluene (5 mL) and DMF (1 mL), and the reaction solution was stirred at 120° C. for 2.5 hours. The reaction solution was left to cool to room temperature. Then, ethyl acetate and saturated sodium bicarbonate water were added to the reaction solution, and the organic layer was separated. The resulting organic layer was dried over anhydrous magnesium sulfate and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (carrier: Chromatorex™ NH; elution solvent: ethyl acetate->ethyl acetate:methanol=5:1) to obtain 1 mg of 1-(4-fluorophenyl)-3-{(E)-2-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]vinyl}-5,6-dihydro-8H-imidazo[5,1-c][1,4]oxazine and 2 mg of 2-{4-(4-fluorophenyl)-5-methoxymethyl-2-{(E)-2-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]vinyl}imidazol-1-yl}ethanol.
Workup
- filtrationThe suspension was filtered through celite
- concentrationthe filtrate was concentrated under reduced pressure
- additionp-Toluenesulfonic acid monohydrate (6 mg) was added to a solution of the resulting residue in toluene (5 mL)
- stirringDMF (1 mL), and the reaction solution was stirred at 120° C. for 2.5 hours
- waitThe reaction solution was left
- temperatureto cool to room temperature
- additionThen, ethyl acetate and saturated sodium bicarbonate water were added to the reaction solution
- customthe organic layer was separated
- dry with materialThe resulting organic layer was dried over anhydrous magnesium sulfate
- concentrationconcentrated under reduced pressure
- customThe residue was purified by silica gel column chromatography (carrier: Chromatorex™ NH; elution solvent: ethyl acetate->ethyl acetate:methanol=5:1)
Sources & evidence
- ORD record
- ord-e084c90a379b4adcb42dedfd71286f61
- Source dataset
- uspto-grants-2011_07
- Patent number
- US07973033B2
Reaction notes
Loading…